Harvard Medical School study finds removing race from lung function estimations could shift disease severity categorization, impacting disability payments, diagnoses, and job eligibility.
A study from Harvard Medical School predicts that removing race from lung function estimations will shift categorization of disease severity, moving more Black individuals into an advanced disease category while reclassifying more white and Hispanic people as having less advanced illness. The study, published in the New England Journal of Medicine, suggests that race-neutral lung assessments may have profound effects on disability payments, disease diagnoses, and job eligibility.
May 19, 2024
5 Articles